Showing results (471-480 of 551) with videos related to

Sort By:
Pageof 56
Cancer Prevention Research (Philadelphia, Pa.)|December 15, 2010
Transition of a clinical trial into translational research: the prostate cancer prevention trial experiencePhyllis J Goodman, Catherine M Tangen, Alan R Kristal, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 30, 2017
A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT CohortsElizabeth A Platz, Ibrahim Kulac, John R Barber, et al.
The New England Journal of Medicine|June 26, 2003
The influence of finasteride on the development of prostate cancerIan M Thompson, Phyllis J Goodman, Catherine M Tangen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group StudyAnita L Sabichi, J Jack Lee, Robert J Taylor, et al.
Journal of the National Cancer Institute|April 6, 2006
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patientsFadlo R Khuri, J Jack Lee, Scott M Lippman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2006
Fenretinide activity in retinoid-resistant oral leukoplakiaScott M Lippman, J Jack Lee, Jack W Martin, et al.
Oncoimmunology|December 8, 2018
Immunological and classical subtypes of oral premalignant lesionsJean-Philippe Foy, Chloé Bertolus, Sandra Ortiz-Cuaran, et al.
Journal of the National Cancer Institute|September 13, 2007
Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention TrialM Scott Lucia, Jonathan I Epstein, Phyllis J Goodman, et al.
Prostate Cancer and Prostatic Diseases|May 6, 2015
Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancerM H Umbehr, B Gurel, T J Murtola, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 26, 2012
Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancerKatherine D Crew, Powel Brown, Heather Greenlee, et al.
Pageof 56